Mobocertinib (TAK788)

Mobocertinib (TAK788, AP32788), an investigational TKI, is a potent, selective preclinical inhibitor of epidermal growth factor receptor (EGFR) and HER2 mutations. Mobocertinib (TAK788) is an antineoplastic agent.
Supplier Selleck Chemicals
Product # S6813
Sku # S6813-25mg
Pricing 25mg, $237.00
Feedback